NCT07369674

Brief Summary

Background Cystic echinococcosis (hydatid cyst) is a significant zoonotic disease endemic to Iraq. Understanding the localized clinical and epidemiological trends is vital for improving surgical outcomes and public health strategies. Objective To determine the epidemiological and clinical profile of patients diagnosed with liver hydatid cysts within the hospitals of Najaf City, Iraq.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
350

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 2, 2021

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 5, 2024

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 5, 2025

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

January 5, 2026

Completed
22 days until next milestone

First Posted

Study publicly available on registry

January 27, 2026

Completed
Last Updated

January 27, 2026

Status Verified

January 1, 2026

Enrollment Period

3.3 years

First QC Date

January 5, 2026

Last Update Submit

January 17, 2026

Conditions

Hydatid Cyst, Hepatic

Outcome Measures

Primary Outcomes (1)

  • To determine the epidemiological and clinical profile of patients diagnosed with liver hydatid cysts within the hospitals of Najaf City, Iraq.

    This retrospective observational study analyzed the records of 350 patients treated for liver hydatid cysts across multiple hospitals in Najaf, Iraq, from February 2021 to June 2024.

    February 2021 to June 2024

Eligibility Criteria

Age9 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This retrospective, observational study was conducted on a total of 350 patients diagnosed with liver hydatid cysts. The study was carried out at multiple centers in Najaf City, Iraq, including major governmental surgical hospitals and specialized centers, covering the period from February 2021 to June 2024.

You may qualify if:

  • All patients of any age or gender with a radiologically or surgically confirmed diagnosis of liver hydatid cyst

You may not qualify if:

  • Patients with hydatid cysts located exclusively in extra-hepatic sites (e.g., brain, lung, bone, spleen, or muscle). Patients with severe chronic comorbidities or incomplete medical records were also excluded to ensure data integrity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alkafeel

Najaf, 00964, Iraq

Location

MeSH Terms

Conditions

Echinococcosis, Hepatic

Condition Hierarchy (Ancestors)

EchinococcosisCestode InfectionsHelminthiasisParasitic DiseasesInfectionsLiver Diseases, ParasiticLiver DiseasesDigestive System Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
350 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dean

Study Record Dates

First Submitted

January 5, 2026

First Posted

January 27, 2026

Study Start

February 2, 2021

Primary Completion

June 5, 2024

Study Completion

March 5, 2025

Last Updated

January 27, 2026

Record last verified: 2026-01

Locations

IR(1)